University of Lubeck-ko ikertzaileekin lankidetzan egindako argitalpenak (4)

2016

  1. 1-Year Outcomes With Intracoronary Abciximab in Diabetic Patients Undergoing Primary Percutaneous Coronary Intervention

    Journal of the American College of Cardiology, Vol. 68, Núm. 7, pp. 727-738

  2. Pooled Analysis Comparing the Efficacy of Intracoronary Versus Intravenous Abciximab in Smokers Versus Nonsmokers Undergoing Primary Percutaneous Coronary Revascularization for Acute ST-Elevation Myocardial Infarction

    American Journal of Cardiology, Vol. 118, Núm. 12, pp. 1798-1804

2015

  1. Intracoronary abciximab in diabetic patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention

    Vascular Pharmacology, Vol. 73, pp. 32-37

2014

  1. Effects of baseline coronary occlusion and diabetes mellitus in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention

    American Journal of Cardiology, Vol. 114, Núm. 8, pp. 1145-1150